Belharra co-founder and researcher at The Scripps Research Institute, Dr. Chris Parker, published his foundational research in Cell. This research was foundational to the development of Belharra’s proprietary chemoproteomics platform and its ability to target the undrugged proteome.
News
TIMELINE SINGLE TEMPLATE